Steps Against the Burden of Parkinson's Disease - StepuP | NCT06538909 | Trialant
Not yet recruitingInterventionalNot ApplicableUpdated Aug 6, 2024
Steps Against the Burden of Parkinson's Disease - StepuP
Steps Against the Burden of Parkinson's Disease - StepuP
ClinicalTrials.gov ID
NCT06538909
Lead Sponsor
Tel-Aviv Sourasky Medical CenterOTHER_GOV
Overall Status
Not yet recruiting
Study Type
Interventional
Phase
Not Applicable
Enrollment
21Estimated
Last Update Posted
Aug 6, 2024Actual
Start Date
Sep 2024Estimated
Primary Completion Date
Dec 2025Estimated
Completion Date
Dec 2025Estimated
Official Title
Steps Against the Burden of Parkinson's Disease - StepuP
Brief Summary
The goals of our StepuP project are:
To understand the kinematic and neural mechanisms underlying walking improvements due to treadmill training with and without VR-enabled gait adaptations in people with PD;
To assess to what extent improvements in walking due to treadmill training, as measured in the laboratory, transfer to improvements in daily life mobility;
To understand the mechanisms underlying the transfer from improvements in walking to improvements in mobility in daily life in people with PD;
To understand for whom treadmill training improves walking characteristics in the laboratory and for whom it does not, and to understand for whom treadmill training improves mobility in daily life and for whom it does not.
Parkinson Disease
VR
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Specific criteria for Parkinson's disease - PD
Diagnosis of Parkinson's disease according to the MDS World Movement Disorders Society criteria Disease severity H&Y I-III
Score section 3.10 (ability to walk) MDS-UPDRS 3.10 ≥ 1
MoCA cognitive assessment > 15
Stable cardiovascular condition, ability to perform aerobic activity at low to moderate intensity
Without orthopedic diseases and other diseases that affect the quality of walking, at the decision of the researcher.
Exclusion Criteria:
Moderate or severe depression (BDI-II ≥18)
Orthopedic diseases and other diseases that affect the quality of walking, at the decision of the researcher